To investigate whether HMMR mediates the influence of FIGNL1 on ECM-receptor interaction pathway remodeling, we used HepG2 human liver cancer cell line to knock down HMMR on the basis of FIGNL1 overexpression. The gene discussed is FIGNL1; the disease is liver cancer.